Methods of treating Parkinson's disease
US11091507B2 · kind B2 · utility
1Cited by
13References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2020 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | May 4, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa prodrug, and (c) methods of treating Parkinson's disease and associated conditions comprising administering a carbidopa prodrug and an L-dopa prodrug to a subject with Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.